Pharma Industry News

NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer

With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]